; and (B) not later than 45 days after the request is made, or such a later time as requested by the applicant. (3) (A) A person who is registered to conduct research with a controlled substance in schedule I may, notwithstanding subsections (a) and (b), conduct research with another controlled substance in schedule I, if each of following conditions are met: (i) The person has applied for a modification of the person’s registration to authorize research with such other controlled substance in accordance with the regulations issued by the Attorney General. (ii) The Attorney General has obtained verification from the Secretary that the research protocol submitted with the application is meritorious. (iii) The Attorney General has determined under subparagraph (B) that the conduct of such research is consistent with United States obligations under the Single Convention on Narcotic Drugs, 1961. (B) Not later than 30 days after receiving an application under clause (i), the Attorney General shall determine whether the conduct of research that is the subject of the application is consistent with United States obligations under the Single Convention on Narcotic Drugs, 1961. (C) Nothing in this section shall be construed to alter the authority of the Attorney General to initiate proceedings to deny, suspend, or revoke any registration in accordance with sections 303 and 304. . (f) Treatment of certain activities as coincident to research Section 302 of the Controlled Substances Act ( 21 U.S.C. 822 ), as amended by subsections (a), (c), and (e), is further amended by adding at the end the following new subsection: (i) A person who is registered to perform research with a controlled substance (other than marihuana) under this title may, without being required to registered to manufacture such substance, using small quantities of such substance, perform the following activities: (1) Processing the substance to create extracts, tinctures, oils, solutions, derivatives, or other forms of the substance consistent with the